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Abstract 
The antibiogram of nasal methicillin resistant Staphylococcus aureus (MRSA) from pregnant women attending 
University of Uyo Teaching Hospital was investigated using standard microbiological procedures. Out of 
772 women, 180(23.3%) harboured nasal MRSA while 592 (76.7%) had MSSA (Methicillin Sensitive 
Staphylococcus aureus). The highest frequency (33.3%) occured at week 16 while the lowest occured at week 
36 of the pregnancy period. Evaluation by logistic regression showed no risk factor involvement for MRSA. 
The patients were evaluated on their first visit (booking) therefore the MRSA were likely community-acquired. 
Antibiogram of isolates showed sensitivity mostly to clindamycin (80%), amoxacillin-clavulanic acid (76.7%), 
ceftriazone (69.4%) and resistance to co-trimoxazole (51.7%). The asymptomatic nasal colonisation of MRSA 
in pregnant women may therefore be a risk factor for serious systemic infection after delivery. 
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1. Introduction 
Most staphylococci are resistant to penicillin due to 
the production of β-lactamase. A positive β-lactamase 
test indicates resistance to pencillin, ampicillin, 
amoxillin, azlocillin, carbenicillin, mezlocillin, 
piperacillin and ticacillin1. Resistance to the 
antistaphylococcal, penicillinase-stable penicillins 
(methicillin, nafcillin and oxacillin) has been referred 
to as “methicillin resistance”. 
Most resistance to oxacillin in staphylococci is 
mediated by the mecA gene which directs the 
production of a supplemental penicillin-binding 
protein, PBP2a in the cell wall of resistant strains2. 
MRSA appeared in 1961 shortly after the introduction 
of methicillin in clinical practice and its prevalence in 
US hospitals approached 50% in 20043. MRSA has 
been shown to be one of the most common causes of 
nosocomial infections accounting for 40 to 70% of S. 
aureus infections in intensive care unit4. It also causes 
infections in neonatal intensive care unit5, among 
families as well as in pregnant and postpartum 
women6. Infection with MRSA is likely to be more 
severe and requires longer hospitalization7. 
The study of nasal carriage of MRSA is important to 
the community since carriage plays a key role in the 
epidemiology and pathogenesis of Community 
Associated MRSA (CAMRSA). CAMRSA having 
the PVL gene is associated with skin infections like 
furuncles and with necrotizing pneumonia8. 
The treatment options of MRSA are limited to few 
antibiotics like vancomycin, linezolid and 
teigecycline. Since there are reports of reduced 
susceptibility and resistance of S. aureus to 
vancomycin from different countries especially Japan 
and USA9, the study was conducted to determine 
current prevalence of MRSA as well as antimicrobial 
susceptibility patterns of isolates from pregnant 
women. This is because the presence of MRSA in 
anterior nares of these women could pose a 
pregnancy-related threat to both mother and neonate. 
2. Materials and Methods 
2.1 Source of samples 
Swab specimens were obtained from antenatal 
attendees at the University of Uyo Teaching Hospital, 
Uyo. The hospital is a tertiary facility with 7,250 beds 
and serves as a referral centre. All the women 
consented to participation in the study and permission 
from the hospital authority was obtained. 
2.2 Collection of samples 
A swab specimen from the anterior nares was 
obtained from each pregnant women involved in the 
study. Swabs were carefully inserted into each nostril 
so that the tip is entirely at the nasal osteum level 
(about 2.5 cm from the edge of the nares) and rolled 
gently 4 times. 
2.3 Culture procedures and isolation 
The swabs were immeditately plated on blood agar 
and on mannitol-salt agar and incubated for 24 hours 
at 35oC. Mannitol fermenting colonies were 
subcultured and identified by morphology, 
microscopy and biochemical tests1. 
2.4 Screen test for MRSA  
A suspension equivalent to MacFarland 0.5 was 
prepared from each isolate. A swab was dipped and 
surface-plated on Mueller-Hinton agar. Thirty (30)µg 
oxacillin disk was placed on the medium and the 
plates incubated at 35oC for 24 hours. Plates with 
inhibition zones less than 12mm were considered 
methicillin resistant while those with zones greater 
than 13mm were susceptible. 
2.5 Antibiotic susceptibility test 
The Kirby-Bauer disk diffusion technique was 
adopted. Individual discs of the antibiotics were 
aseptically placed on Mueller-Hinton agar previously 
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seeded with 0.5 MacFarland suspension of each 
isolate. Plates were incubated at 37oC for 24 hours 
and zones of inhibition were recorded. All the MRSA 
isolates were used in the test. 
2.6 Inducible Macrolide Lincomycin 
Streptogramin B (iMLSB) 
All isolates resistant to erythromycin but susceptible 
to clindamycin were subjected to iMLSB test. A 15µg 
erythromycin disc and 2µg clindamycin disc (Oxoid 
Ltd, Cambridge, UK) were placed 15-26mm apart on 
an already S. aureus seeded Mueller-Hinton agar 
plate. The plates were incubated for 18-24 hours at 
35oC. Isolates that showed a flattening of the 
clindamycin zone of inhibition adjacent to the 
erythromycin disc (referred to as D-zone) were 
considered to exhibit inducible clindamycin 
resistance. 
2.7 Data anaylsis 
Data were analysed using SPSS software involving 
regression and correlation. 
 
3. Results 
Figure 1 represents the distribution of MRSA and 
Methicillin Sensitive Staphylococcus aureus (MSSA) 
among antenatal attendees. Exactly 23.33% of the 
isolates were MRSA while 76.67% were MSSA. 
Figure 2 shows the frequency of occurence of MRSA 
with age. The highest frequency was obtained at age 
31 years.  
The frequency of occurence of MRSA at different 
gestational ages is shown on Figure 3. The highest 
frequency (33.3%) occured at week 16 while the 
lowest (3.3%) was at week 36 of the pregnancy 
period.  
Table 1 shows the risk factors associated with MRSA 
colonisation in the attendees. Exactly 86.7% of the 
attendees were not previously admitted in the 
hospital, did not visit clinics and were not on any 
form of antimicrobials during the pregnancy period. 
Table 2 shows the antibiotic susceptibility patterns of 
MRSA isolates. The isolates where mostly sensitive 
to clindamycin, amoxycillin-clavulanic acid and 
ceftriazone with susceptibilities of 80%, 76.7% and 
69.4% respectively. The isolates were however 
resistant to cotrimozaxole. 
Table 3 shows frequency of inducible macrolide 
streptogramin B. The MRSA isolates exhibited 31.1% 
resistance to erythromycin, 20% to clindamycin, 
29.4% to ceftriazone, 35.6% to ciprofloxacin, 51.7% 
to sulfamethoxazole-trimetoprim and 22.2% to 
amoxillin-clavulanic acid. 
 
4. Discussion 
Methicillin resistant S. aureus has evolved as one of 
the most important causes of nosocomial infections 
worldwide. The data obtained from this study 
revealed that 23.33% antenatal women in the study 
area harboured MRSA in their anterior nares. 
However, 45% colonization by MRSA in health care 
workers was obtained in India10, while 36.2% 
colonization by MRSA occured in 9 Provinces in 
Iran11. Also, it was reported that 47% of all S. aureus 
isolates from US intensive care units in 1998 were 
methicillin-resistant12. The prevalence of MRSA 
among clinical specimens has been found to be 
23.9%13 and in other reports, the prevalence ranged 
from 20% to 32.8% 14, 15. The prevalence of MRSA in 
some countries is still low. In the Netherlands for 
example, it is as low as 1%16. Thus the prevalence 
differ from one geographical location to another. 
Different epidemiological factors such as 
geographical and health system capability in running 
infection control programme influence the variability 
of prevalence of MRSA11. 
There was negative correlation between gestatinal age 
(GA) and antimcrobial use (P=0.001) ie women at 
early GA are more likely to take antibiotics than those 
at a later GA age.  
Although some reports show signicantly increased 
rate of MRSA in elderly people 17, 18, in this study, 
there was no significant difference between MRSA 
colonization and age. Apart from pregnancy, age is a 
risk factor because of its role in long term 
hospitalization, loss of immunity and longer antibiotic 
therapy19. 
From the study, the MRSA isolates were community 
acquired because 86.7% of the attendees were not 
previously admitted in the hospital and 80% had no 
clinic visit history, therefore, no risk factor for 
colonisation by MRSA was noted. 
Identifying the incidence of MRSA infections within 
the community would imply the existence of 
significant reserviors of MRSA colonization within 
the community. It holds important implications for 
efforts to control the emergence of glycopeptide 
resistance among staphylococci. Recognising the 
emergence of CAMRSA might serve as a warning 
that MRSA control measures have failed12. 
The importance of a dose-effect association, 
supporting a causal relationship between MRSA and 
antimicrobial drug use has been demonstrated20. 
However, in the study, 96.7% of attendees were not 
exposed to antimicrobial use.  
In this study, the isolates were susceptible to 
clindamycin, amoxycillin-clavulanic acid and 
ceftriazone but resistant to cotrimoxazole (51.7%). A 
100% resistance of MRSA to penicillin, co-
amoxyclav and ampicillin and more than 70% 
resistance to cefotaxinic, erythromycin, ceftriaxone 
and nalidixic acid has been reported11. 
 
5. Conclusion 
The MRSA isolates were community acquired and 
therefore no risk factor for colonisation was observed. 
Accurate and early detection of these strains in 
hospitals and community is encouraged. Also, a 
systematic review of isolation policies in the hospitals 
management of MRSA coupled with increased 
compliance with hand hygiene recommendation could 
lead to a significant reduction in MRSA.  
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Risk factor Frequency Percentage (%) 
Previous Hospital Admissions none 156 86.7 
 Last 3 months 18 10.0 
 Last 12 months 6 3.3 
Clinic Visit None 144 80 
 Last 3 months 24 13.3 
 Last 6 months 12 6.7 
Antimicrobial use history none 174 96.7 
 Last 3 months 6 3.3 
 
Table 2: Susceptibility pattern of MRSA isolates 
 
Antibiotics Frequency Susceptibility (%) 
Ciprofloxacin 114 63.3 
Cotrimoxazole 84 46.7
Amoxycillin-clavulanic acid 138 76.7 
Erythromycin 120 66.7 
Clindamycin 144 80.0
Ceftriazone 125 69.4 
 
 
Table 3: Frequency of Inducible Microlide streptogramin B 
 
Antibiotics Frequency (R) Percentage (%) 
Ciprofloxacin 64 35.6 
Cotrimoxazole 93 51.7 
Amoxycillin-clavulanic acid 53 29.4 
Erythromycin 56 31.1 
Clindamycin 36 20.0 
Ceftriazone 53 29.4 
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